A phase II trial of marimastat in advanced pancreatic cancer

Pancreatic cancer has a poor response to conventional chemotherapy and radiotherapy. Inhibition of matrix metalloproteinase activity involved in tumour invasion and metastases is a novel biological approach for cancer treatment. This multicentre phase II clinical trial assessed marimastat, an oral m...

詳細記述

保存先:
書誌詳細
主要な著者: Evans, J D, Stark, A, Johnson, C D, Daniel, F, Carmichael, J, Buckels, J, Imrie, C W, Brown, P, Neoptolemos, J P
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 2001
主題:
Regular Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2364022/
https://ncbi.nlm.nih.gov/pubmed/11747327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2001.2168
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料